Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Praziquantel. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104557911A details a chemo-enzymatic route for (R)-praziquantel. This method ensures high optical purity and significant cost reduction in anthelmintic drug manufacturing.
Novel enzymatic dynamic kinetic resolution for high-purity (R)-praziquantel. Reduces cost and improves supply chain reliability for API manufacturing.
Novel one-pot process for praziquantel reduces waste and improves yield. Ideal for pharmaceutical intermediates manufacturing scale-up and cost reduction.
Patent CN108358916B details solvent-free ball milling for high-purity R-Praziquantel. Reduces cost and waste for reliable pharmaceutical intermediate supply chains.
Novel one-pot praziquantel synthesis reduces costs and improves yield. Reliable supply chain for pharmaceutical intermediates with stringent quality control.
Patent CN101445507B details a streamlined 3-step synthesis for praziquantel, offering significant cost reduction in pharmaceutical intermediates manufacturing and improved supply chain reliability.
Patent CN107814797B reveals catalytic hydrogenation to recover wasted S-praziquantel intermediate, enabling cost-effective L-praziquantel production.
Patent CN105237532A reveals enzymatic route for L-praziquantel. Offers high optical purity and greener manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN102925528B reveals a novel nitrilase-catalyzed route for high-purity levo-praziquantel intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Discover the novel one-pot preparation process for Praziquantel in patent CN103570710A. Achieve high purity yields over 95% with reduced waste and simplified operations for industrial scale-up.
Patent CN107151246A details chiral resolution for levo-praziquantel. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chains.
Patent CN104557911B reveals enzymatic deracemization for levo-praziquantel. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Patent CN107151246B reveals cost-effective chiral resolution. Reliable supplier for high-purity levo-praziquantel intermediates with scalable processes.